Return to homepagePandemic Pact

Rethink the Strip: Stopping Glucose Monitoring for Non-Insulin Treated Type 2 Diabetes

  • Funded by Patient-Centered Outcomes Research Institute
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $466,752

  • Funder

    Patient-Centered Outcomes Research Institute

  • Principal Investigator

    MD. Katrina Donahue

  • Research Location

    United States of America

  • Lead Research Institution

    The University of North Carolina at Chapel Hill

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Health Personnel

Abstract

Patients with type 2 diabetes go to clinic regularly to check their A1C levels. They also have a higher risk of serious complications from COVID-19. Patients may be unsure how to balance going to clinic with reducing risks of getting COVID-19. With the enhancement, the team will explore strategies patients and their healthcare providers can use to stay on top of their blood glucose control as well as stay healthy and safe during the pandemic. Our team will help providers answer common questions about diabetes care during COVID-19. This new information will be included in the Re-think the Strip Program.